Cody Simmons | Source | CEO at DermaSensor
Cody Simmons
Cody, CEO at DermaSensor who has achieved internet-fame in late Jan 2024, when it received FDA approval for its approach using non-invasive spectroscopy for skin cancer and melanoma detection. As a bioengineer and entrepreneur, Cody has spent all of his career bringing new health technologies to physicians and patients. He is a frequent speaker at health technology and entrepreneurship events, and Cody was included on the Forbes 30 Under 30 in healthcare.
-
DermaSensor gains FDA clearance for its AI-powered skin cancer detection device - Refresh Miami
It’s been a long journey, but the road to the US market is now full speed ahead for Miami-based healthcare technology company DermaSensor. Today, the startup
Article
-
This is a long-standing unmet clinical need. This is something very well recognized from a population health standpoint. Primary care providers that are assessing suspicious lesions can really provide a lot of benefit to all healthcare stakeholders – patients, clinicians, payers, etc.
